Smith & Nephew plc
$32.71
▼
-0.4%
2026-04-22 10:12:13
www.smith-nephew.com
NYQ: SNN
Explore Smith & Nephew plc stock price, valuation, financial statements, dividend history, analyst estimates, and long-term business fundamentals on StockSifting.
Market Cap
$14.01 B
Current Price
$32.71
52W High / Low
$1,441.5 / $960.8
Stock P/E
22.84
Book Value
$6.22
Dividend Yield
2.29%
ROCE
9.67%
ROE
11.84%
Face Value
—
EPS
$1.43
Exp Qtr EPS
—
Sector
Healthcare
Industry
Medical Devices
Employees
16,988
Beta
0.74
Debt / Equity
62.9
Current Ratio
2.57
Quick Ratio
1.25
Forward P/E
16.02
Price / Sales
2.32
Enterprise Value
$31.22 B
EV / EBITDA
23.37
EV / Revenue
5.07
Rating
None
Target Price
$36.62
EPS Forecast (FY)
—
Pros
- Short-term liquidity looks comfortable.
- Net margin remains healthy.
- Meaningful dividend yield is available.
Cons
- Some data points may be missing or delayed because the source is not an official exchange feed.
Sift Stocks
| S.No. | Name | Price | P.E. | Market Cap | Div Yld % | ROCE | ROE | 52Week High/ Low | Book Value |
|---|---|---|---|---|---|---|---|---|---|
| 1. | Delcath Systems, Inc. | $10.88 | 139.76 | $377.34 M | — | 0.59% | 3% | $18.23 / $8.12 | $3.21 |
| 2. | DexCom, Inc. | $63.4 | 30.77 | $24.57 B | — | 21.72% | 34.5% | $89.98 / $54.11 | $7.14 |
| 3. | ClearPoint Neuro, Inc. | $11.16 | — | $349.74 M | — | -27.78% | -95.64% | $30.1 / $8.27 | $0.95 |
| 4. | Orthofix Medical Inc. | $12.65 | — | $507.83 M | — | -12.14% | -19.34% | $16.99 / $10.24 | $11.3 |
| 5. | Tenon Medical, Inc. | $0.8 | — | $9.06 M | — | -169.5% | -2.28% | $2.48 / $0.64 | $0.18 |
| 6. | Beta Bionics, Inc. | $12.91 | — | $576.08 M | — | -24.07% | -40.26% | $32.71 / $8.8 | $6.48 |
| 7. | Electromed, Inc. | $25.4 | 23.98 | $215.65 M | — | 22.29% | 20.2% | $30.73 / $17.73 | $5.49 |
Quarterly Results
Figures shown in M / B
| Sales |
|---|
| Operating Profit |
| Net Profit |
| EPS in Rs |
Profit & Loss
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Sales | 6.16 B | 5.81 B | 5.55 B | 5.21 B |
| Operating Profit | 857 M | 860 M | 620 M | 634 M |
| Net Profit | 625 M | 412 M | 263 M | 223 M |
| EPS in Rs | 1.46 | 0.97 | 0.62 | 0.52 |
Balance Sheet
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Total Assets | 10.46 B | 10.35 B | 9.99 B | 9.97 B |
| Total Liabilities | 5.17 B | 5.09 B | 4.77 B | 4.71 B |
| Equity | 5.29 B | 5.26 B | 5.22 B | 5.26 B |
| Current Assets | 4.1 B | 4.42 B | 4.03 B | 3.86 B |
| Current Liabilities | 1.59 B | 1.53 B | 2.27 B | 1.72 B |
Cash Flow
Last available yearly cash flow history
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Operating CF | 1.28 B | 987 M | 608 M | 468 M |
| Investing CF | -406 M | -569 M | -448 M | -472 M |
| Financing CF | -955 M | -86 M | -200 M | -926 M |
| Free CF | 852 M | 606 M | 181 M | 110 M |
| Capex | -433 M | -381 M | -427 M | -358 M |
5Y Margin & Growth History
Last 5 year derived history from yfinance annual statements
| 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|
| Revenue Growth % | 4.7% | 6.4% | — | — |
| Earnings Growth % | 56.65% | 17.94% | — | — |
| Profit Margin % | 7.09% | 4.74% | 4.28% | — |
| Operating Margin % | 14.8% | 11.17% | 12.16% | — |
| Gross Margin % | 69.64% | 68.82% | 70.47% | — |
| EBITDA Margin % | 21.02% | 17.23% | 16.76% | — |
Dividend & Split History
Latest dividend and stock split events stored from yfinance
Dividend History
| Ex Date | Dividend |
|---|---|
| 2026-03-27 | $0.482 |
| 2025-10-03 | $0.3 |
| 2025-03-28 | $0.462 |
| 2024-10-04 | $0.288 |
| 2024-04-01 | $0.462 |
Stock Splits
No stock split history available.